What is the use of clomipramine

Clomipramine, sold under the brand name Anafranil among others, is a tricyclic antidepressant (TCA). It is used for the treatment of obsessive–compulsive disorder, panic disorder, major depressive disorder, and chronic pain. It may decrease the risk of suicide in those over the age of 65. It is taken by mouth. This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.-Some experts recommend: Use is not recommended. CLOMIPRAMINE is an antidepressant. It is used to treat obsessive-compulsive disorder. The lowest GoodRx price for the most common version of clomipramine is around $84.49, 64% off the average retail price of $238.50. Anafranil (clomipramine hydrochloride) is a tricyclic antidepressant used to treat symptoms of obsessive-compulsive disorder such as recurrent thoughts or feelings and repetitive actions. Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for CLOMIPRAMINE HYDROCHLORIDE. How to use Clomipramine HCL. Read the Medication Guide provided by your pharmacist before you start taking clomipramine and each time you get a refill. Technical Service: Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others. Clomipramine Hydrochloride Capsules USP is an antiobsessional drug that belongs to the class (dibenzazepine) of pharmacologic agents known as tricyclic antidepressants. Clomipramine (Anafranil) is a tricyclic antidepressant. You can find detailed information about this drug in the official Patient Information Leaflet (PIL), including what it's for, how to take it, possible side effects and safety information. Adults. Clomipramine capsules are indicated for the treatment of: - the symptoms of depressive illness especially where sedation is required - obsessional and phobic states.

Buy What is the use of clomipramine

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*